The volume of enhancement of disease (VED) predicts the early response to treatment and overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib
Campani, C., Colagrande, S., Calistri, L., Dragoni, G., Lorini, C., Castellani, A., Marra, F.Volume:
52
Journal:
Digestive and Liver Disease
DOI:
10.1016/j.dld.2019.12.053
Date:
February, 2020
File:
PDF, 309 KB
2020